|
It was reported that approximately 4 days following the implant of a transcatheter aortic valve, the patient was re-hospitalized with a fever, fatigue, body aches, episodes of dizziness with standing, vomiting, diarrhea, and hypotension.Endocarditis was confirmed, with staphylococci the organism that was cultured.The patient was administered ceftriaxone and vancomycin to treat the infection.Approximately 27 days following the initial re-hospitalization, the valve was explanted.
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|